Statement Regarding Privacy Policy

Most Read

Australian company Vaxxas receives significant investment from Endpoints Capital
October 3, 2024 - Latest News
New Alliance to drive increased procurement of homegrown medtech
October 3, 2024 - Latest News
Nyrada’s says lead drug candidate demonstrates significant cardioprotection
October 3, 2024 - Latest News
Cartherics raises over $15 million in private financing round
October 3, 2024 - Latest News

New Stories

New Alliance to drive increased procurement of homegrown medtech
October 3, 2024 - - Latest News
Australian company Vaxxas receives significant investment from Endpoints Capital
October 3, 2024 - - Latest News
Cartherics raises over $15 million in private financing round
October 3, 2024 - - Latest News
Nyrada’s says lead drug candidate demonstrates significant cardioprotection
October 3, 2024 - - Latest News
AusBiotech welcomes more new members from across Australia's life sciences ecosystem
October 1, 2024 - - AusBiotech
Percheron Therapeutics updates on Avicursen primate toxicology study
October 1, 2024 - - Latest News
Mesoblast option to issue up to US$50 million convertible notes for product launch
October 1, 2024 - - Latest News